Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Modeling the effect of school closures in a pandemic scenario: exploring two different contact matrices.

Fung IC, Gambhir M, Glasser JW, Gao H, Washington ML, Uzicanin A, Meltzer MI.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S58-63. doi: 10.1093/cid/civ086.

PMID:
25878302
2.

Modeling rates of infection with transient maternal antibodies and waning active immunity: application to Bordetella pertussis in Sweden.

Feng Z, Glasser JW, Hill AN, Franko MA, Carlsson RM, Hallander H, Tüll P, Olin P.

J Theor Biol. 2014 Sep 7;356:123-32. doi: 10.1016/j.jtbi.2014.04.020. Epub 2014 Apr 23.

PMID:
24768867
3.

Smallpox eradication in Bangladesh, 1972-1976.

Foster SO, Hughes K, Tarantola D, Glasser JW.

Vaccine. 2011 Dec 30;29 Suppl 4:D22-9. doi: 10.1016/j.vaccine.2011.06.081. Epub 2011 Dec 19. Review.

PMID:
22188934
4.

Modeling the impact of RV144-like vaccines on HIV transmission.

Hankins CA, Glasser JW, Chen RT.

Vaccine. 2011 Aug 18;29(36):6069-71. doi: 10.1016/j.vaccine.2011.07.001. Epub 2011 Jul 14. No abstract available.

PMID:
21762753
5.

Modeling and public health emergency responses: lessons from SARS.

Glasser JW, Hupert N, McCauley MM, Hatchett R.

Epidemics. 2011 Mar;3(1):32-7. doi: 10.1016/j.epidem.2011.01.001. Epub 2011 Jan 28.

PMID:
21420657
6.

Projected Impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children <5 years of age during 2006-2015.

Curns AT, Coffin F, Glasser JW, Glass RI, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S49-56. doi: 10.1086/605036.

7.

Mumps resurgences in the United States: A historical perspective on unexpected elements.

Barskey AE, Glasser JW, LeBaron CW.

Vaccine. 2009 Oct 19;27(44):6186-95. doi: 10.1016/j.vaccine.2009.06.109. Review.

PMID:
19815120
8.

Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics.

Pitzer VE, Viboud C, Simonsen L, Steiner C, Panozzo CA, Alonso WJ, Miller MA, Glass RI, Glasser JW, Parashar UD, Grenfell BT.

Science. 2009 Jul 17;325(5938):290-4. doi: 10.1126/science.1172330.

9.

Timely identification of optimal control strategies for emerging infectious diseases.

Feng Z, Yang Y, Xu D, Zhang P, McCauley MM, Glasser JW.

J Theor Biol. 2009 Jul 7;259(1):165-71. doi: 10.1016/j.jtbi.2009.03.006. Epub 2009 Mar 14.

PMID:
19289133
10.

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4.

11.

Evaluating public health responses to reintroduced smallpox via dynamic, socially structured, and spatially distributed metapopulation models.

Glasser JW, Foster SO, Millar JD, Lane JM.

Clin Infect Dis. 2008 Mar 15;46 Suppl 3:S182-94. doi: 10.1086/524382.

12.

Reducing the global burden of congenital rubella syndrome: report of the World Health Organization Steering Committee On Research Related To Measles and Rubella Vaccines and Vaccination, June 2004.

Best JM, Castillo-Solorzano C, Spika JS, Icenogle J, Glasser JW, Gay NJ, Andrus J, Arvin AM.

J Infect Dis. 2005 Dec 1;192(11):1890-7. Epub 2005 Oct 31.

13.

Development of a rubella vaccination strategy: contribution of a rubella susceptibility study of women of childbearing age in Kyrgyzstan, 2001.

Malakmadze N, Zimmerman LA, Uzicanin A, Shteinke L, Caceres VM, Kasymbekova K, Sozina I, Glasser JW, Joldubaeva M, Aidyralieva C, Icenogle JP, Strebel PM, Reef SE.

Clin Infect Dis. 2004 Jun 15;38(12):1780-3. Epub 2004 May 17.

14.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

15.

Emerging and reemerging infectious diseases: a multidisciplinary perspective.

Stephens DS, Moxon ER, Adams J, Altizer S, Antonovics J, Aral S, Berkelman R, Bond E, Bull J, Cauthen G, Farley MM, Glasgow A, Glasser JW, Katner HP, Kelley S, Mittler J, Nahmias AJ, Nichol S, Perrot V, Pinner RW, Schrag S, Small P, Thrall PH.

Am J Med Sci. 1998 Feb;315(2):64-75.

PMID:
9472905
16.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

Chen RT, Glasser JW, Rhodes PH, Davis RL, Barlow WE, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Vadheim CM, Marcy SM, Ward JI, Wise RP, Wassilak SG, Hadler SC.

Pediatrics. 1997 Jun;99(6):765-73.

PMID:
9164767
17.

Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects. The Vaccine Safety Datalink Investigators.

Wassilak SG, Glasser JW, Chen RT, Hadler SC.

Ann N Y Acad Sci. 1995 May 31;754:377-82. No abstract available.

PMID:
7625677
18.

Prevention of fetal wastage: the obstetrician's point of view.

GLASSER JW.

J Int Coll Surg. 1956 Jan;25(1 Part 1):53-64. No abstract available.

PMID:
13286498
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk